AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership for its lead candidate, intranasal 5-MeO-DMT (BPL-003) for treatment-resistant depression (TRD), sources close to the company told Psychedelic Alpha. Here, we take a closer look...
External link. We are not responsible for the content.
Read more ↗More From Psychedelic Alpha
Pα+ February 2026 Psychedelic Bill Roundup
A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including ...
The State of the Psychedelic Industry & Open Questions (Video)
In the third video of a three-part series, Psychedelic Alpha’s Josh Hardman takes a look at some broader open questio...
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
In this conversation with Psychedelic Alpha’s Josh Hardman, Dr. Terence Ching discusses his journey into the field an...
Latest News
Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?
PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn...
The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of p...
A new “magic mushroom” drug could treat depression without psychedelic hallucinations
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending s...
The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 2)
Psychedelic therapy, due to the combination of heightened suggestibility, powerful altered states, and unique power i...
AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills
Plus: Pilot study uses psilocybin for post-treatment Lyme disease and Psychedelic-assisted therapy bill rejected then...
Global Altered States: LA’s 2C-B Economy
New Series: Global Altered States